Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234804 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Even though patients achieved major response after preoperative CRT, pretreatment clinical stage is an important prognostic marker for recurrence and survival. Patients with MRD have an increased recurrence risk but similar survival compared with patients achieved PCR.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Min Kyoung M.D., Ph.D., Kyung-Ja M.D., Ph.D., Seung-Il M.D., Ph.D., Yong Hee M.D., Ph.D., Jong Hoon M.D., Ph.D., Ho-Young M.D., Ph.D., Ji Hoon M.D., Ph.D., Hwoon Yong M.D., Ph.D., Gin Hyug M.D., Ph.D., Kee Don M.D., Ph.D., Ho June M.D., Ph.D.,